Artículos por temáticas

Race modifies the relationship between cognition and Alzheimer's disease cerebrospinal fluid biomarkers

Howell JC, Watts KD, Parker MW, Wu J, Kollhoff A, Wingo TS, Dorbin CD, Qiu D, Hu WT.

Alzheimers Res Ther. 2017 Nov 2;9(1):88. doi: 10.1186/s13195-017-0315-1.

Radiopharmaceuticals for Assessment of Altered Metabolism and Biometal Fluxes in Brain Aging and Alzheimer's Disease with Positron Emission Tomography

Xie F, Peng F.

J Alzheimers Dis. 2017;59(2):527-536. doi: 10.3233/JAD-170280.

Diagnostic Accuracy of Memory Measures in Alzheimer's Dementia and Mild Cognitive Impairment: a Systematic Review and Meta-Analysis

Weissberger GH, Strong JV, Stefanidis KB, Summers MJ, Bondi MW, Stricker NH.

Neuropsychol Rev. 2017 Dec;27(4):354-388. doi: 10.1007/s11065-017-9360-6. Epub 2017 Sep 22.

A Quantitative Analysis of Brain Soluble Tau and the Tau Secretion Factor

Han P, Serrano G, Beach TG, Caselli RJ, Yin J, Zhuang N, Shi J.

J Neuropathol Exp Neurol. 2017 Jan 1;76(1):44-51. doi: 10.1093/jnen/nlw105.

Blood-Brain Glucose Transfer in Alzheimer's disease: Effect of GLP-1 Analog Treatment

Gejl M, Brock B, Egefjord L, Vang K, Rungby J, Gjedde A.

Sci Rep. 2017 Dec 13;7(1):17490. doi: 10.1038/s41598-017-17718-y.

Blood Biomarkers for Alzheimer's Disease: Much Promise, Cautious Progress

Keshavan A, Heslegrave A, Zetterberg H, Schott JM.

Mol Diagn Ther. 2017 Feb;21(1):13-22. doi: 10.1007/s40291-016-0241-0.

The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer's disease

Ritchie CW, Russ TC, Banerjee S, Barber B, Boaden A, Fox NC, Holmes C, Isaacs JD, Leroi I, Lovestone S, Norton M, O'Brien J, Pearson J, Perry R, Pickett J, Waldman AD, Wong WL, Rossor MN, Burns A.

Alzheimers Res Ther. 2017 Oct 26;9(1):85. doi: 10.1186/s13195-017-0312-4.

Effects of Diabetes Mellitus on Cognitive Decline in Patients with Alzheimer Disease: A Systematic Review

Li J, Cesari M, Liu F, Dong B, Vellas B.

Can J Diabetes. 2017 Feb;41(1):114-119. doi: 10.1016/j.jcjd.2016.07.003. Epub 2016 Sep 7.

Increased Pittsburgh Compound-B Accumulation in the Subcortical White Matter of Alzheimer's Disease Brain

Wakabayashi Y, Ishii K, Hosokawa C, Hyodo T, Kaida H, Yamada M, Yagyu Y, Tsurusaki M, Kozuka T, Sugimura K, Murakami T.

Kobe J Med Sci. 2017 Mar 13;62(5):E136-E141.

FDG-PET for Prediction of AD Dementia in Mild Cognitive Impairment. A Review of the State of the Art with Particular Emphasis on the Comparison with Other Neuroimaging Modalities (MRI and Perfusion SPECT)

Sanchez-Catasus CA, Stormezand GN, van Laar PJ, De Deyn PP, Sanchez MA, Dierckx RA.

Curr Alzheimer Res. 2017;14(2):127-142. doi: 10.2174/1567205013666160629081956.

[Current and future prospects of nuclear medicine in dementia]

Ito K, Inui Y, Kizawa T, Kimura Y, Kato T.

Rinsho Shinkeigaku. 2017 Sep 30;57(9):479-484. doi: 10.5692/clinicalneurol.cn-001016. Epub 2017 Aug 11.

Semantic Memory in the Clinical Progression of Alzheimer Disease

Tchakoute CT, Sainani KL, Henderson VW; Raloxifene in Alzheimer’s Disease Investigators.

Cogn Behav Neurol. 2017 Sep;30(3):81-89. doi: 10.1097/WNN.0000000000000131.

Beyond Acetylcholinesterase Inhibitors: Novel Cholinergic Treatments for Alzheimer's Disease

Kamkwalala AR, Newhouse PA.

Curr Alzheimer Res. 2017;14(4):377-392. doi: 10.2174/1567205013666160930112625.

[Doctor, is my mother suffering from dementia?]

Scheltens P, Gillissen F, Bouwman FH, van der Flier WM.

Ned Tijdschr Geneeskd. 2017;161:D2086.

Alzheimer's Disease Caregivers' Health and Important Resources: Next Steps in Intervention Research

Ross KM, Carroll JE.

Psychosom Med. 2017 Sep;79(7):732-734. doi: 10.1097/PSY.0000000000000518.